EA
RDY icon

Emerald Acquisition’s Dr. Reddy's Laboratories RDY Stock Holding History

Emerald Acquisition’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.02M Sell
109,685
-230,155
-68% -$2.2M ﹤0.01% 2129
2016
Q2 		$3.48M Buy
+339,840
New +$3.11M 0.01% 1554

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's RDY Position: Q3 2016 in Review

Emerald Acquisition reduced its Dr. Reddy's Laboratories (RDY) stake by 68% in Q3 2016, selling an estimated $2.2M and leaving 109,685 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Emerald Acquisition first reported a position in RDY in Q2 2016 and has held it in 2 quarters since. The position peaked at $3.48M in Q2 2016. 156 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • Emerald Acquisition held 109,685 shares of Dr. Reddy's Laboratories worth $1.02M as of Q3 2016.
  • Emerald Acquisition sold 230,155 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $2.2M.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2129 holding.
  • Emerald Acquisition first reported a position in Dr. Reddy's Laboratories in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Dr. Reddy's Laboratories position peaked at $3.48M in Q2 2016.
  • 156 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.